Overview

Long Term Tapering or Standard Steroids for Nephrotic Syndrome

Status:
Unknown status
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Parallel group double blind randomised in patients with first episode corticosteroid sensitive nephrotic syndrome comparing time to relapse and adverse effects associated with a longer tapering steroid regimen with standard regime
Phase:
Phase 4
Details
Lead Sponsor:
Institute of Child Health
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate